查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631528

合成小分子 API 市场规模、份额、趋势分析报告：按製造商、应用、地区、细分市场预测，2025-2030 年

Synthetic Small Molecule API Market Size, Share & Trends Analysis Report By Manufacturer (In-house, Outsourced), By Application (Oncology, Pulmonology, CNS, Endocrinology), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

合成小分子 API 市场的成长与趋势

根据 Grand View Research, Inc. 的新报告，全球合成小分子 API 市场规模预计将在 2030 年达到 2,574 亿美元，2025-2030 年期间的复合年增长率为 5.6%。这是由全球对药品和新型小分子药物日益增长的需求所推动的。此外，小分子 API 在剂型方面更加灵活，且更易于精製，从而获得了更广泛的接受度和需求。

随着合成药物在製药业变得越来越普遍，对小原料药等生产原料的需求预计会增加。此外，与现有产品的增强相关的技术进步有望为小分子疗法提供新的机会。例如，2022年3月，赢创宣布其新颖的EUDRATEC SoluFlow技术，以增强口服小分子的溶解度。

这个市场受到各个地区政府对原料药製造的积极支持所推动，尤其是在亚洲，那里的大多数原料药製造商都依赖原料药供应来生产合成小分子原料药 。人们对外包原料药生产的兴趣也日益浓厚。例如，2020年4月，为了应对COVID-19，Wavelength Pharmaceuticals扩大了治疗重症患者所需的某些药物的关键原料药的供应，并推出了API CDMO服务。中国、印度和东南亚等新兴市场提供了巨大的成长机会。

亚洲製造商专注于可大规模生产的较不复杂的分子，因此对新技术和复杂技术的投资相对较少。因此，对于欧洲、北美等其他已开发地区的製造商来说，投资高产量、低成本的技术是对冲竞争压力的一种选择。

市场中的主要企业正致力于合作生产强大的 API 产品。例如，2021年8月，Almac Sciences与Pila Pharma达成协议，生产高活性和选择性小分子TRPV1拮抗剂API XEN-D0501。此外，CDMO 也在不断发展，扩大其产能以满足日益增长的合成药物需求。例如，AGC Inc.于 2022 年 4 月宣布将扩大其在西班牙的合成药物生产设施 7,500 平方米，预计该地区对合成小分子原料药的需求将增加。

合成小分子 API 市场报告重点

  • 整体市场的成长归因于原料需求的增加导致药品产量的上升。
  • API 市场正在经历重大转变，人们越来越倾向于使用 CDMO 来大规模生产合成小分子药物原料药。
  • 根据製造商的数据，由于中小企业依赖商业製造外包，预计外包部分将在预测期内呈现最快的复合年增长率。
  • 根据应用，心血管疾病领域因其慢性特性和全球高盛行率而占据市场主导地位，到 2024 年市场占有率为 21.7%。
  • 由于主要企业的存在以及政府对加强该地区 API 製造能力的支持不断增加，北美在 2024 年占据了市场主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 合成小分子 API 市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析 – 波特五力分析
    • PESTLE分析

第 4 章合成小分子 API 市场：製造商业务分析

  • 2024 年及 2030 年製造商市场占有率
  • 製造商细分仪表板
  • 2018 年至 2030 年製造商市场规模、预测与趋势分析
  • 内部
  • 外包

5. 合成小分子 API 市场：应用业务分析

  • 2024 年和 2030 年应用市场占有率
  • 应用程式细分仪表板
  • 2018 年至 2030 年按应用分類的市场规模、预测与趋势分析
  • 心血管疾病
  • 肿瘤学
  • 中枢神经系统和神经病学
  • 整形外科
  • 外包
  • 内分泌学
  • 呼吸系统医疗设备
  • 胃肠病学
  • 肾臟科
  • 眼科
  • 其他的

第六章合成小分子 API 市场：区域估计和趋势分析、製造商和应用

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Merck &Co., Inc.
    • AbbVie, Inc.
    • Bristol-Myers Squibb Company
    • Albemarle Corporation
    • Boehringer Ingelheim International GmbH
    • Cipla, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Aurobindo Pharma
    • Sun Pharmaceutical Industries Ltd.
Product Code: GVR-4-68039-976-3

Synthetic Small Molecule API Market Growth & Trends:

The global synthetic small molecule API market size is estimated to reach USD 257.4 billion by 2030, registering a CAGR of 5.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. This can be attributed to the increasing demand for pharmaceuticals and new small molecule-based drugs globally. Moreover, small molecules API offers versatility between dosage forms and has an easier means of purification, which makes it more acceptable and increases the demand.

There is an increasing dominance of synthetic drugs in the pharmaceutical industry, which is expected to propel the requirement of raw materials such as small molecule APIs for production. Moreover, technological advancements related to the enhancement of existing products are expected to provide new opportunities for small molecule therapeutics. For instance, in March 2022, Evonik launched the new EUDRATECSoluFlow technology that enhances the solubility of oral small molecules.

The market is driven by positive government support for the production of APIs in various regions, particularly in Asia, where the majority of API manufacturers are dependent on the supply of API for the production of synthetic small molecule APIs. There has been an increasing focus on outsourcing activities for API production. For instance, in April 2020, for managing COVID-19, Wavelength Pharmaceuticals expanded the supply of key drug ingredients for certain pharmaceutical products needed to manage respiratory critical care patients and launched API CDMO services. Emerging markets such as China, India, and Southeast Asia represent significant opportunities for growth.

The investment in new and complex technologies is relatively low for Asian manufacturers as they are more focused on less complex molecules that can be produced in bulk. Thus, the investment in high-yielding, low-cost technologies is an alternative for manufacturers in other developed regions such as Europe and North America to avoid competitive pressure.

Key players operating in the market are focusing on collaboration for the production of potent API products. For instance, in August 2021, Almac Sciences signed an agreement with Pila Pharma for the production of the API XEN-D0501, a highly potent and selective small molecule TRPV1 antagonist. Moreover, CDMOs are constantly evolving by expanding their capacities to meet the heightened demand for synthetic drugs. For instance, in April 2022, AGC Inc. announced the expansion of its Spanish facility by 7500 m2 for synthetic pharmaceutical production, which is expected to enhance the demand for synthetic small molecule active pharmaceutical ingredients in the region.

Synthetic Small Molecule API Market Report Highlights:

  • The growth of the overall market is attributed to the increasing production of pharmaceuticals with the increased demand for raw material
  • The API market is witnessing a key shift with the rise in the preference for CDMOs for the production of synthetic small molecule active pharmaceutical ingredients in bulk
  • By manufacturer, the outsourced segment is expected to witness fastest CAGR over the forecast period, owing to a dependency of small and mid-sized companies on outsourcing for commercial production
  • By application, the cardiovascular diseases segment dominated the market in 2024 with a market share of 21.7%, owing to their chronic nature and high global prevalence.
  • North America dominated the market in 2024, due to the presence of key players and rising support from the government for enhancing the API manufacturing capacity of the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Manufacturer
    • 1.2.2. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Synthetic Small Molecule API Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Synthetic Small Molecule API Market: Manufacturer Business Analysis

  • 4.1. Manufacturer Market Share, 2024 & 2030
  • 4.2. Manufacturer Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Manufacturer, 2018 to 2030 (USD Billion)
  • 4.4. In-house
    • 4.4.1. In-house Market, 2018 - 2030 (USD Billion)
  • 4.5. Outsourced
    • 4.5.1. Outsourced Market, 2018 - 2030 (USD Billion)

Chapter 5. Synthetic Small Molecule API Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Billion)
  • 5.5. Oncology
    • 5.5.1. Oncology Market, 2018 - 2030 (USD Billion)
  • 5.6. CNS and Neurology
    • 5.6.1. CNS and Neurology Market, 2018 - 2030 (USD Billion)
  • 5.7. Orthopedic
    • 5.7.1. Orthopedic Market, 2018 - 2030 (USD Billion)
  • 5.8. Outsourced
    • 5.8.1. Outsourced Market, 2018 - 2030 (USD Billion)
  • 5.9. Endocrinology
    • 5.9.1. Endocrinology Market, 2018 - 2030 (USD Billion)
  • 5.10. Pulmonology
    • 5.10.1. Pulmonology Market, 2018 - 2030 (USD Billion)
  • 5.11. Gastroenterology
    • 5.11.1. Gastroenterology Market, 2018 - 2030 (USD Billion)
  • 5.12. Nephrology
    • 5.12.1. Nephrology Market, 2018 - 2030 (USD Billion)
  • 5.13. Ophthalmology
    • 5.13.1. Ophthalmology Market, 2018 - 2030 (USD Billion)
  • 5.14. Others
    • 5.14.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 6. Synthetic Small Molecule API Market: Regional Estimates & Trend Analysis Manufacturer and Application

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Europe
    • 6.5.1. Europe Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden Synthetic Small Molecule API Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Billion)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. Australia Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. South Korea Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Latin America
    • 6.7.1. Latin America Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. MEA
    • 6.8.1. MEA Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Merck & Co., Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. AbbVie, Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Bristol-Myers Squibb Company
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Albemarle Corporation
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Boehringer Ingelheim International GmbH
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Cipla, Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Dr. Reddy's Laboratories Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Aurobindo Pharma
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Sun Pharmaceutical Industries Ltd.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global synthetic small molecule API market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 5 Global synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 6 North America synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 8 North America synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 9 U.S. synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 10 U.S. synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 11 Canada synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 12 Canada synthetic small molecule API market, by Application, 2018 - 2030 (USD Billion)
  • Table 13 Mexico synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 14 Mexico synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 15 Europe synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 16 Europe synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 17 Europe synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 18 UK synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 19 UK synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 20 Germany synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 21 Germany synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 22 France synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 23 France synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 24 Italy synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 25 Italy synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 26 Spain synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 27 Spain synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 28 Denmark synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 29 Denmark synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 30 Sweden synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 31 Sweden synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 32 Norway synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 33 Norway synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 34 Asia Pacific synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 36 Asia Pacific synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 37 Japan synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 38 Japan synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 39 China synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 40 China synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 41 India synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 42 India synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 43 Australia synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 44 Australia synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 45 South Korea synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 46 South Korea synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 47 Thailand synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 48 Thailand synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 49 Latin America synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 50 Latin America synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 51 Latin America synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 52 Brazil synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 53 Brazil synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 54 Argentina synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 55 Argentina synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 56 Middle East & Africa synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 57 Middle East & Africa synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 58 Middle East & Africa synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 59 South Africa synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 60 South Africa synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 61 Saudi Arabia synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 63 UAE synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 64 UAE synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 65 Kuwait synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 66 Kuwait synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Synthetic small molecule API market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Manufacturer and application outlook (USD Billion)
  • Fig. 9 Competitive landscape
  • Fig. 10 Synthetic small molecule API market dynamics
  • Fig. 11 Synthetic small molecule API market: Porter's five forces analysis
  • Fig. 12 Synthetic small molecule API market: PESTLE analysis
  • Fig. 13 Synthetic small molecule API market: Manufacturer segment dashboard
  • Fig. 14 Synthetic small molecule API market: Manufacturer market share analysis, 2024 & 2030
  • Fig. 15 In-house market, 2018 - 2030 (USD Billion)
  • Fig. 16 Outsourced market, 2018 - 2030 (USD Billion)
  • Fig. 17 Synthetic small molecule API market: Application segment dashboard
  • Fig. 18 Synthetic small molecule API market: Application market share analysis, 2024 & 2030
  • Fig. 19 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
  • Fig. 20 Oncology market, 2018 - 2030 (USD Billion)
  • Fig. 21 CNS and neurology market, 2018 - 2030 (USD Billion)
  • Fig. 22 Orthopedic market, 2018 - 2030 (USD Billion)
  • Fig. 23 Endocrinology market, 2018 - 2030 (USD Billion)
  • Fig. 24 Pulmonology market, 2018 - 2030 (USD Billion)
  • Fig. 25 Gastroenterology market, 2018 - 2030 (USD Billion)
  • Fig. 26 Nephrology market, 2018 - 2030 (USD Billion)
  • Fig. 27 Ophthalmology market, 2018 - 2030 (USD Billion)
  • Fig. 28 Others market, 2018 - 2030 (USD Billion)
  • Fig. 29 Synthetic small molecule API market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 33 U.S. country dynamics
  • Fig. 34 U.S. synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 35 Canada country dynamics
  • Fig. 36 Canada synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 37 Mexico country dynamics
  • Fig. 38 Mexico synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 39 Europe synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 44 France country dynamics
  • Fig. 45 France synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 54 Norway country dynamics
  • Fig. 55 Norway synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 56 Asia Pacific synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 59 China country dynamics
  • Fig. 60 China synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 61 India country dynamics
  • Fig. 62 India synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 69 Latin America synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 72 Argentina country dynamics
  • Fig. 73 Argentina synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 74 MEA synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 75 South Africa country dynamics
  • Fig. 76 South Africa synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 77 Saudi Arabia country dynamics
  • Fig. 78 Saudi Arabia synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 79 UAE country dynamics
  • Fig. 80 UAE synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 81 Kuwait country dynamics
  • Fig. 82 Kuwait synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 83 Company categorization
  • Fig. 84 Company market position analysis
  • Fig. 85 Strategic framework